AEHR vs HIMX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AEHR shows bearish fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Concerns include weak profitability or high valuation.
HIMX exhibits a strong operational health profile with a Piotroski F-Score of 7/9, yet this is overshadowed by severe fundamental deterioration. The stock is significantly overvalued relative to its Graham Number ($5.47) and Intrinsic Value ($1.82), while trading at a high P/E of 35.42 despite crashing YoY earnings (-74.20%) and revenue (-14.40%). Most critically, the dividend is unsustainable with a payout ratio of 142.31%, indicating the company is returning more capital than it generates.
Compare Another Pair
Related Comparisons
AEHR vs HIMX: Head-to-Head Comparison
This page compares Aehr Test Systems, Inc. (AEHR) and Himax Technologies, Inc. (HIMX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.